The consistent number of Gal-3+ cells both in PIN lesions and in metastatic lymph nodes suggests that Gal-3 expression is not restricted to CSCs, and indeed, we have found that Gal-3 is also produced by more differentiated human and murine prostate cancer cells. This evidence concerns the gene LGALS3 and prostate carcinoma.